Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan; Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, Michigan.
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.
Cell Mol Gastroenterol Hepatol. 2020;10(4):797-810. doi: 10.1016/j.jcmgh.2020.05.013. Epub 2020 Jun 2.
BACKGROUND & AIMS: Intestinal crypts have a remarkable capacity to regenerate after injury from loss of crypt base columnar (CBC) stem cells. After injury, facultative stem cells (FSCs) are activated to replenish the epithelium and replace lost CBCs. Our aim was to assess the role of insulin-like growth factor-1 (IGF-1) to activate FSCs for crypt repair.
The intestinal regenerative response was measured after whole body 12-Gy γ-irradiation of adult mice. IGF-1 signaling or its downstream effector mammalian target of rapamycin complex 1 (mTORC1) was inhibited by administering BMS-754807 or rapamycin, respectively. Mice with inducible Rptor gene deletion were studied to test the role of mTORC1 signaling in the intestinal epithelium. FSC activation post-irradiation was measured by lineage tracing.
We observed a coordinate increase in growth factor expression, including IGF-1, at 2 days post-irradiation, followed by a surge in mTORC1 activity during the regenerative phase of crypt repair at day 4. IGF-1 was localized to pericryptal mesenchymal cells, and IGF-1 receptor was broadly expressed in crypt progenitor cells. Inhibition of IGF-1 signaling via BMS-754807 treatment impaired crypt regeneration after 12-Gy irradiation, with no effect on homeostasis. Similarly, rapamycin inhibition of mTORC1 during the growth factor surge blunted the regenerative response. Analysis of Villin-CreER;Rptor mice showed that epithelial mTORC1 signaling was essential for crypt regeneration. Lineage tracing from Bmi1-marked cells showed that rapamycin blocked FSC activation post-irradiation.
Our study shows that IGF-1 signaling through mTORC1 drives crypt regeneration. We propose that IGF-1 release from pericryptal cells stimulates mTORC1 in FSCs to regenerate lost CBCs.
肠隐窝在因丢失隐窝基底部柱状细胞(CBC)干细胞而受损后,具有很强的再生能力。受损后,兼性干细胞(FSCs)被激活以补充上皮并替代丢失的 CBC。我们的目的是评估胰岛素样生长因子 1(IGF-1)在激活 FSCs 以修复隐窝中的作用。
通过全身 12-Gy γ-辐照成年小鼠来测量肠道再生反应。分别通过给予 BMS-754807 或雷帕霉素来抑制 IGF-1 信号或其下游效应物哺乳动物雷帕霉素靶蛋白复合物 1(mTORC1)。研究诱导型 Rptor 基因缺失的小鼠,以测试 mTORC1 信号在肠道上皮中的作用。通过谱系追踪来测量辐照后 FSC 的激活。
我们观察到,在辐照后 2 天,生长因子表达(包括 IGF-1)协同增加,随后在第 4 天的隐窝修复再生阶段,mTORC1 活性激增。IGF-1 定位于隐窝周围的间质细胞,IGF-1 受体广泛表达于隐窝祖细胞中。通过 BMS-754807 治疗抑制 IGF-1 信号会损害 12-Gy 辐照后的隐窝再生,但对稳态没有影响。同样,在生长因子激增期间,通过雷帕霉素抑制 mTORC1 会使再生反应减弱。Villin-CreER;Rptor 小鼠的分析表明,上皮细胞 mTORC1 信号对隐窝再生至关重要。从 Bmi1 标记的细胞进行的谱系追踪表明,雷帕霉素阻断了辐照后 FSC 的激活。
我们的研究表明,IGF-1 通过 mTORC1 信号驱动隐窝再生。我们提出,来自隐窝周围细胞的 IGF-1 释放刺激 FSCs 中的 mTORC1 以再生丢失的 CBC。